{
    "name": "Reserve standards; life insurance policies or riders",
    "number": "10H-224",
    "text": "[\u00a7431:10H-224]\u00a0 Reserve standards; life insurance policies or riders.\u00a0 (a)\u00a0 When long-term care benefits are provided through the acceleration of benefits under group or individual life policies or riders to these policies, the policy reserves for the benefits shall be determined in accordance with section 431:5-307.\u00a0 Claim reserves shall also be established in the case where the policy or rider is in claim status.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Reserves for policies subject to this section shall be based on the multiple decrement model utilizing all relevant decrements except for voluntary termination rates.\u00a0 Single decrement approximations are acceptable if the calculation produces essentially similar reserves, if the reserve is clearly more conservative, or if the reserve is immaterial.\u00a0 The calculations may take into account the reduction in life insurance benefits due to the payment of long-term care benefits.\u00a0 However, in no event shall the reserves for the long-term care benefit and the life insurance benefit be less than the reserves for the life insurance benefit assuming no long-term care benefit.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 In the development and calculation of reserves for policies and riders subject to this section, due regard shall be given to applicable policy provisions, marketing methods, administrative procedures, and all other considerations which have an impact on projected claim costs, including but not limited to the following:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Definition of insured events;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Covered long-term care facilities;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Existence of home convalescence care coverage;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Definition of facilities;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Existence or absence of barriers to eligibility;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Premium waiver provision;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Renewability;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Ability to raise premiums;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Marketing method;\n\u00a0\u00a0\u00a0 (10)\u00a0 Underwriting procedures;\n\u00a0\u00a0\u00a0 (11)\u00a0 Claims adjustment procedures;\n\u00a0\u00a0\u00a0 (12)\u00a0 Waiting period;\n\u00a0\u00a0\u00a0 (13)\u00a0 Maximum benefit;\n\u00a0\u00a0\u00a0 (14)\u00a0 Availability of eligible facilities;\n\u00a0\u00a0\u00a0 (15)\u00a0 Margins in claim costs;\n\u00a0\u00a0\u00a0 (16)\u00a0 Optional nature of benefit;\n\u00a0\u00a0\u00a0 (17)\u00a0 Delay in eligibility for benefit;\n\u00a0\u00a0\u00a0 (18)\u00a0 Inflation protection provisions; and\n\u00a0\u00a0\u00a0 (19)\u00a0 Guaranteed insurability option.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Any applicable valuation morbidity table shall be certified as appropriate as a statutory valuation table by a member of the American Academy of Actuaries. [L 1999, c 93, pt of \u00a72]"
}